Acute kidney injury in patients receiving pembrolizumab combination therapy versus pembrolizumab monotherapy for advanced lung cancer

ICPi-AKI Consortium

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
JournalKidney International
DOIs
StatePublished - Oct 2022

Cite this